- Goethe JW. Die Leiden des jungen Werther. Anaconda, 2005.
- King J. Lethal beauty: suicides by location. San Francisco Chronicle, November 4, 2005.
- National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. Atlanta, GA: Centers for Disease Control and Prevention, 2005. Available from www.cdc.gov/ncipc/wisqars; accessed April 10, 2008.
- Conwell Y, Duberstein PR, Caine ED. Risk factors for suicide in later life. Biol Psychiatry 2002;52 (3): 193–204.
- Durkheim É. On Suicide. Stennet R, Riley A, Buss R, eds. New York: Penguin Classics, 2007.
- Conwell Y, Brent D. Suicide and aging. I: Patterns of psychiatric diagnosis. Int Psychogeriatr 1995;7 (2): 149–164.
- Conwell Y. Suicide in later life: a review and recommendations for prevention. Suicide Life Threat Behav 2001;31 (Suppl): 32–47.
- Hybels CF, Blazer DG. Epidemiology of late-life mental disorders. Clin Geriatr Med 2003;19 (4): 663–696.
- Narrow WE. One-year prevalence of mental disorders, excluding substance use disorders, in the U.S.: NIMH ECA prospective data. Population estimates based on U.S. Census estimated residential population age 18 and over on July 1, 1998. Unpublished.
- Alexopoulos GS. Mood disorders. In Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry, 7th ed., vol. 2. Baltimore: Williams & Wilkins, 2000.
- Donovan S, Kelleher MJ, Lambourn J, Foster T. The occurrence of suicide following the prescription of antidepressant drugs. Arch Suicide Res 1999;5 (3): 181–192.
- Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003;60 (10): 978–982.
- Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164 (9): 1356–1363.
- Biddle L, Brock A, Brookes ST, Gunnell D. Suicide rates in young men in England and Wales in the 21st century: time trend study. BMJ 2008;336 (7643): 539–542.
- Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292 (3): 338–343.
- Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005;330 (7488): 389.
- Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163 (1): 41–47.
- Wessely S, Kerwin R. Suicide risk and the SSRIs. JAMA 2004;292 (3): 379–381.
- Barak Y, Olmer A, Aizenberg D. Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology 2006;31 (1): 178–181.
- Healy D, Whitaker C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci 2003;28 (5): 331–337.
- Barak Y, Aizenberg D. Association between antidepressant prescribing and suicide in Israel. Int Clin Psychopharmacol 2006;21 (5): 281–284.
- Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363 (9418): 1341–1345.
- March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; TADS Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004;292 (7): 807–820.
- Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 2006;163 (5): 813–821.
- Food and Drug Administration. Psychopharmacologic Drugs Advisory Committee and Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee: Slides. February 2004. Available at www.fda.gov/ohrms/dockets/ac/04/slides/4006s1.htm; accessed April 10, 2008.
- Moynihan R. FDA advisory panel calls for suicide warnings over new antidepressants. BMJ 2004;328 (7435): 303.
- Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 2006;8 (5 Pt 1): 467–474.
- Simon GE. How can we know whether antidepressants increase suicide risk? Am J Psychiatry 2006;163 (11): 1861–1863.
- Hung YC, Ho YY, Shen CL. Delayed akathisia and suicidal attempts following epidural droperidol infusion—a case report. Acta Anaesthesiol Sin 1999;37 (3): 151–154.
- Drake RE, Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry 1985;142 (4): 499–501.
- Atbasoglu EC, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci 2001;13 (3): 336–341.
- Hansen L. Fluoxetine dose-increment related akathisia in depression: implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia. J Psychopharmacol 2003;17 (4): 451–452.
- National Committee for Quality Assurance. HEDIS Volume 2: Technical Specifications. Washington, DC: 2004.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 21, 2008 - Issue 4